LIF insider sale: weighted avg prices $98.88 and $99.47
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Life360, Inc. (LIF) director John P. Coghlan reported open‑market sales on 11/03/2025 made under a Rule 10b5‑1 trading plan adopted on December 6, 2024. The transactions included 2,866 shares at a weighted average price of $98.88 and 259 shares at a weighted average price of $99.47.
Following the transactions, beneficial ownership reported included 15,235 shares held by the John Coghlan Living Trust, 3,344 shares held directly, and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. Holdings include 2,508 restricted stock units. The filing also notes an exempt transfer of 12,110 shares from the GRAT to the Living Trust pursuant to Rule 16a‑13.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 3,125 shares ($309,153)
Net Sell
4 txns
Insider
COGHLAN JOHN PHILIP
Role
Director
Sold
3,125 shs ($309K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common stock | 2,866 | $98.88 | $283K |
| Sale | Common stock | 259 | $99.47 | $26K |
| holding | Common stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common stock — 15,494 shares (Indirect, Held by the John Coghlan Living Trust);
Common stock — 3,344 shares (Direct);
Common Stock — 55,494 shares (Indirect, Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust)
Footnotes (1)
- The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $98.33 to $99.31, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. The Reporting Person transferred 12,110 shares indirectly held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust to the John Coghlan Living Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $99.36 to $99.60, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. Includes 2,508 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
FAQ
What did Life360 (LIF) director John P. Coghlan sell?
He sold 2,866 shares at a weighted average price of $98.88 and 259 shares at a weighted average price of $99.47 on 11/03/2025.
Were the Life360 (LIF) sales under a 10b5-1 plan?
Yes. The transactions were effected under a Rule 10b5-1 trading plan adopted on December 6, 2024.
What are John P. Coghlan’s reported holdings after the transactions?
15,235 shares held by the Living Trust, 3,344 shares held directly, and 55,494 shares held by the 2025 GRAT.
Do the reported holdings include RSUs?
Yes. The reported holdings include 2,508 restricted stock units, each representing one share upon vesting.
What was the transaction date for the reported sales?
November 3, 2025.